Maria Silva’s family tree, like dozens of others scattered across the misty hillsides of São Miguel Island in the Azores, holds a secret written in genes: a single mutation that can sound like schizophrenia in one voice, autism in another, and silence in a third. For over 30 years, researchers led by Carlos N. Pato and Michele T. Pato have followed 173 families across four generations in this isolated Portuguese archipelago, where centuries of genetic continuity have turned bloodlines into living laboratories. Here, psychiatric diagnoses don’t obey the neat categories of medical textbooks—they blur, overlap, and sometimes vanish into one another like fog over the Atlantic.
The Azores, settled by a small group of Portuguese colonists around 600 years ago, offer a rare genetic clarity. With little outside migration, the population’s DNA has remained largely unchanged—a still pond where even the faintest ripples of rare mutations become visible. In this setting, the Portuguese Island Collection has revealed something profound: in 49 of the 173 families studied—just over 28%—both psychosis and mood disorders like bipolar disorder or severe depression appear in the same lineage. Even more striking, in 12 families (about 7%), autism spectrum disorder and intellectual disability coexist with schizophrenia or mood disorders, challenging the long-standing boundaries between these conditions.
But one family tells the story most vividly. In a three-generation pedigree labeled PIC-9420, whole-genome sequencing uncovered an ultra-rare stop-gain mutation in the CHD2 gene—a variant so uncommon it appears only once in a global database of over 800,000 individuals and was absent from major schizophrenia and bipolar disorder reference sets. CHD2 is typically linked to childhood epilepsy and autism, yet in most carriers within this family, it presents as schizophrenia. In one sibling, the same mutation leads to autism and intellectual disability. The gene doesn’t change—only how it’s expressed.
This discovery underscores a growing truth in psychiatric genetics: diagnoses are not always discrete diseases but different manifestations of shared biological roots. "We went back to the families because the families never honored the boundaries we drew on paper," says Carlos N. Pato, executive chair of the Department of Psychiatry at Rutgers. His team’s work, published in Genomic Psychiatry, doesn’t just map illness—it redefines how we understand inheritance in mental health.
As genomic medicine advances, studies like this offer hope: that by listening to the complexity of real families, rather than forcing them into diagnostic boxes, we may finally begin to see the true architecture of the mind.